Company intelligence / Profile preview

Pantheon Partners

Yavne, Israel

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Pantheon Biosciences was a biotechnology company focused on developing molecular therapeutic tools and antiviral drugs based on novel anti-phage defense systems. Spun out from the Weizmann Institute of Science, the company leveraged bacterial immunity mechanisms to create disruptive tools for biotechnological applications and next-generation molecular engineering. Despite its innovative approach to harnessing the diversity of bacterial immunity for healthcare, the company is currently listed as out of business.

Therapeutic areas: Infectious Diseases
Modalities: Molecular toolsAntiviral drugsProtein
Industry: Biotech

Partnerships

ExploreBioM-VenturesArkin Bio VenturesPontifaxWuXi AppTec Group

Beyond the preview

Go deeper on Pantheon Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pantheon Partners.

Explore the full profile